Key facts
- This page summarizes Gary L. Crocker's Form 4 filing for MERRIMACK PHARMACEUTICALS INC.
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 14 Aug 2023, 16:06.
Gary L. Crocker - 10 Aug 2023 Form 4 Insider Report for MERRIMACK PHARMACEUTICALS INC
- Reporting relationship
- Chairman, President, and Treasurer, Director
- Issuer ticker
- N/A
- Reported as of
- 10 Aug 2023
- Net transaction value
- +$49,904
- SEC form
- 4
- Accepted by SEC
- 14 Aug 2023, 16:06:26 UTC
- Prior SEC filing
- 08 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Gary L. Crocker
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Gary L. Crocker filed Form 4 for MERRIMACK PHARMACEUTICALS INC on 14 Aug 2023.
Change
- Previous filing in this sequence was filed on 08 Jun 2023.
- Current net transaction value: +$49,904.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MACK
transaction
Common Stock
Purchase
- Transaction value
- $25,039
- Shares
- +2,000
- Change %
- +1.5%
- Price
- $12.52
- Shares after
- 133,105
- Date
- 10 Aug 2023
- Ownership
- See footnote
- Footnotes
- F1, F2
MACK
transaction
Common Stock
Purchase
- Transaction value
- $24,865
- Shares
- +2,000
- Change %
- +1.5%
- Price
- $12.43
- Shares after
- 133,105
- Date
- 11 Aug 2023
- Ownership
- See footnote
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.48 to $12.54, inclusive on August 10, 2023. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
Footnote F2
Shares held by Crocker Family Investments, LLC, over which Reporting Person is the Managing Member.
Footnote F3
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.38 to $12.50, inclusive on August 11, 2023. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
SEC remarks
Chairman, President, and Treasurer